focus -WSS

focus

author：hotspot 2025-09-27 16:49:03 - browse：11437

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

LONDON — A U.K. government agency on Tuesday said that it won’t recommend Eli Lilly’s Mounjaro — part of a new class of medications that help patients lose weight — for people with type 2 diabetes without additional evidence.

Mounjaro, also known as tirzepatide, has U.S. approval for type 2 diabetes and is expected to win the regulatory green light for obesity later this year. It is one of several medications, along with Wegovy and Ozempic from Novo Nordisk, that have shown dramatic weight loss results, creating a surge in demand and blockbuster sales expectations.

But in draft guidance, the U.K.’s National Institute for Health and Care Excellence, which assesses the cost-effectiveness of medications, said it had asked Lilly for more data “to address the uncertainties in the clinical evidence, when compared to all relevant alternative treatments.” NICE recommendations are used by the National Health Service to determine whether to provide certain medications.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Updated Covid vaccine has 54% effectiveness, new study suggests

entertainment

WSS

What is the Turing Test that determines if computers can think?

Why Marc Tessier

A former Republican legislative candidate has been charged for his role in the US Capitol riot

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

Why CTE doesn’t keep Americans from enjoying the Super Bowl

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

Wikipedia

focus

hotspot

New air purifier tech could be key to improving indoor air quality

It's time to take a new tack for treating Alzheimer's

DIEP, the 'gold standard' of breast reconstruction, is under threat

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

At least 13 dead in Texas as scorching temps continue

Gene therapy for Afghan refugees’ infant will be fully covered

Jerome Adams on the need for new antivirals for Covid

Unique patient identifier: Experts argue the benefits, pitfalls

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Global cancer cases to surge 77% by 2050, WHO report says

leisure time

Devoted Health’s losses in Medicare Advantage persist

Cano Health’s bankruptcy is a warning for Medicare Advantage

Problems with a popular proposal to regulate AI in health care

Cano Health’s bankruptcy is a warning for Medicare Advantage

The CDC's new social media misinformation war

Why CTE doesn’t keep Americans from enjoying the Super Bowl

knowledge

entertainment

knowledge

hotspot